コンテンツへスキップ
Merck
  • Notes from the field: hospital outbreak of carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase--Denver, Colorado, 2012.

Notes from the field: hospital outbreak of carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase--Denver, Colorado, 2012.

MMWR. Morbidity and mortality weekly report (2013-02-15)
要旨

On August 16, 2012, the Colorado Department of Public Health and Environment was notified of two patients at an acute-care hospital in Denver with carbapenem-resistant Enterobacteriaceae (CRE), specifically Klebsiella pneumoniae (CRKP), isolated from respiratory specimens during July-August. Both isolates produced New Delhi metallo-beta-lactamase (NDM). A review of microbiology records identified a third patient with NDM-producing CRKP isolated from a respiratory specimen, admitted in May. Active surveillance cultures in September identified an additional five patients colonized with NDM-producing CRKP. An investigation was launched by the hospital and the Colorado Department of Public Health and Environment to guide infection control measures and limit transmission.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ペニシリナーゼ Bacillus cereus由来, lyophilized powder, 1,500-3,000 units/mg protein (using benzylpenicillin)
Sigma-Aldrich
β-ラクタマーゼ 緑膿菌由来, recombinant, expressed in E. coli
Sigma-Aldrich
β-ラクタマーゼ Enterobacter cloacae由来, Type IV, lyophilized powder, 0.2-0.6 units/mg protein (using benzylpenicillin)
Sigma-Aldrich
ペニシリナーゼ Bacillus cereus由来, lyophilized, powder, white, ~13 U/mg
Sigma-Aldrich
β-ラクタマーゼ 蛍光菌Pseudomonas fluorescens由来, lyophilized powder, recombinant, expressed in E. coli